来自MSN57 分钟
Jaypirca: A New Beacon of Hope in the Fight Against Chronic Lymphocytic Leukemia
Pirtobrutinib (brand name Jaypirca) could reduce progression or death risk by 46% in patients with chronic lymphocytic ...